241 related articles for article (PubMed ID: 36626449)
1. Use of proton pump inhibitors for the risk of gastric cancer.
Gao H; Li L; Geng K; Teng C; Chen Y; Chu F; Zhao Y
Medicine (Baltimore); 2022 Dec; 101(49):e32228. PubMed ID: 36626449
[TBL] [Abstract][Full Text] [Related]
2. Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies.
Pan S; Thrift AP; Akhdar G; El-Serag HB
Dig Dis Sci; 2023 Sep; 68(9):3732-3744. PubMed ID: 37432532
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
4. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
5. Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication.
Arai J; Miyawaki A; Aoki T; Niikura R; Hayakawa Y; Fujiwara H; Ihara S; Fujishiro M; Kasuga M
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1217-1225.e6. PubMed ID: 38354970
[TBL] [Abstract][Full Text] [Related]
6. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
7. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
[TBL] [Abstract][Full Text] [Related]
8. Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis.
Jiang K; Jiang X; Wen Y; Liao L; Liu FB
J Gastroenterol Hepatol; 2019 Nov; 34(11):1898-1905. PubMed ID: 31206764
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
Waldum HL; Sørdal Ø; Fossmark R
Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
[TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
11. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
12. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
13. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
[TBL] [Abstract][Full Text] [Related]
14. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis.
Peng TR; Wu TW; Li CH
Int J Clin Oncol; 2023 Jan; 28(1):99-109. PubMed ID: 36224477
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of proton pump inhibitors does not affect ectopic and metachronous recurrence of gastric cancer after endoscopic treatment.
Oura H; Matsumura T; Kawasaki Y; Okimoto K; Ishikawa K; Kaneko T; Tokunaga M; Oike T; Imai Y; Yokoyama Y; Akizue N; Maruoka D; Ohta Y; Saito K; Nakagawa T; Arai M; Kato J; Kato N
Scand J Gastroenterol; 2020 Feb; 55(2):209-215. PubMed ID: 32008404
[No Abstract] [Full Text] [Related]
16. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.
Ahn JS; Eom CS; Jeon CY; Park SM
World J Gastroenterol; 2013 Apr; 19(16):2560-8. PubMed ID: 23674860
[TBL] [Abstract][Full Text] [Related]
17. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
Brusselaers N; Sadr-Azodi O; Engstrand L
J Gastroenterol; 2020 Apr; 55(4):453-461. PubMed ID: 31811561
[TBL] [Abstract][Full Text] [Related]
18. Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?
Richman CM; Leiman DA
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1127-1129. PubMed ID: 37655427
[TBL] [Abstract][Full Text] [Related]
19. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis.
Mohammadi K; Yaribash S; Razi B; Dashti-Khavidaki S
J Clin Pharm Ther; 2022 May; 47(5):567-574. PubMed ID: 34931328
[TBL] [Abstract][Full Text] [Related]
20. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy.
Li CM; Zhernakova A; Engstrand L; Wijmenga C; Brusselaers N
Aliment Pharmacol Ther; 2020 Feb; 51(4):410-420. PubMed ID: 31909512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
